Johnson & Johnson (JNJ) Consolidated Net Income (2009 - 2026)
Johnson & Johnson's Consolidated Net Income came in at $5.53 billion for Q2 2026, down 0.1% from $5.54 billion a year earlier but up 5.7% from the prior quarter.
Johnson & Johnson (JNJ) Consolidated Net Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 28, 2026, Johnson & Johnson reported Consolidated Net Income of $21.04 billion, down 7.2% year-over-year; for FY2025, it came in at $26.8 billion, up 90.6% from FY2024.
- Consolidated Net Income carries a four-year compound annual growth rate of 16.2% (FY2021 to FY2025).
- Going back by year, Consolidated Net Income was $14.07 billion in FY2024 (-60.0%), $35.15 billion in FY2023 (+95.9%), $17.94 billion in FY2022 and $14.71 billion in FY2021.
- The five-year range for quarterly Consolidated Net Income is -$68 million (Q1 2023) to $26.03 billion (Q3 2023).
- Year-over-year, Consolidated Net Income increased in four of the last eight quarters, with growth averaging 29.9%.
- The fastest year-over-year change in Consolidated Net Income over five years came in Q1 2025 (growth of 237.9%), and the weakest in Q3 2024 (a decline of 89.6%).
- Business Quant data shows JNJ's Consolidated Net Income at $5.24 billion (Q1 2026), $5.12 billion (Q4 2025) and $5.15 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 5.53 Bn |
| Mar 29, 2026 | 5.24 Bn |
| Dec 28, 2025 | 5.12 Bn |
| Sep 28, 2025 | 5.15 Bn |
| Jun 29, 2025 | 5.54 Bn |
| Mar 30, 2025 | 11.00 Bn |
| Dec 29, 2024 | 3.43 Bn |
| Sep 29, 2024 | 2.69 Bn |
| Jun 30, 2024 | 4.69 Bn |
| Mar 31, 2024 | 3.26 Bn |
| Dec 31, 2023 | 4.05 Bn |
| Oct 1, 2023 | 26.03 Bn |
| Jul 2, 2023 | 5.14 Bn |
| Apr 2, 2023 | -68.00 Mn |
| Jan 1, 2023 | 3.52 Bn |
| Oct 2, 2022 | 4.46 Bn |
| Jul 3, 2022 | 4.81 Bn |
| Apr 3, 2022 | 5.15 Bn |
| Oct 3, 2021 | 3.67 Bn |
| Jul 4, 2021 | 6.28 Bn |
Johnson & Johnson Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=JNJ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();